We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 8th:
AmerisourceBergen Corporation : This distributor of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Arch Capital Group Ltd. (ACGL - Free Report) : This provider of property, casualty, and mortgage insurance and reinsurance products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
Adamas Pharmaceuticals, Inc. : This developer of medicines for patients suffering from chronic neurologic disorders has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for July 8th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 8th:
AmerisourceBergen Corporation : This distributor of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
AmerisourceBergen Corporation Price and Consensus
AmerisourceBergen Corporation price-consensus-chart | AmerisourceBergen Corporation Quote
AmerisourceBergen's shares gained 3.8% over the last one month more than S&P 500’s rise of 3.6%. The company possesses a Momentum Score of A.
AmerisourceBergen Corporation Price
AmerisourceBergen Corporation price | AmerisourceBergen Corporation Quote
Arch Capital Group Ltd. (ACGL - Free Report) : This provider of property, casualty, and mortgage insurance and reinsurance products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
Arch Capital Group Ltd. Price and Consensus
Arch Capital Group Ltd. price-consensus-chart | Arch Capital Group Ltd. Quote
Arch Capital's shares gained 7.2% over the last one month. The company possesses a Momentum Score of B.
Arch Capital Group Ltd. Price
Arch Capital Group Ltd. price | Arch Capital Group Ltd. Quote
Adamas Pharmaceuticals, Inc. : This developer of medicines for patients suffering from chronic neurologic disorders has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
Adamas Pharmaceuticals, Inc. Price and Consensus
Adamas Pharmaceuticals, Inc. price-consensus-chart | Adamas Pharmaceuticals, Inc. Quote
Adamas’ shares gained 30.5% over the last one month. The company possesses a Momentum Score of B.
Adamas Pharmaceuticals, Inc. Price
Adamas Pharmaceuticals, Inc. price | Adamas Pharmaceuticals, Inc. Quote
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
Aercap Holdings N.V. price-consensus-chart | Aercap Holdings N.V. Quote
AerCap’s shares gained 6.9% over the last one month. The company possesses a Momentum Score of B.
Aercap Holdings N.V. Price
Aercap Holdings N.V. price | Aercap Holdings N.V. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>